
SLCO1B1
ProteinWikipedia
4
MENTIONS
3
EPISODES
3
PODCASTS
Search complete. 4 mentions across 3 episodes found for "SLCO1B1".
Oct 21, 2026
Precision Medicine & Longevity: Your DNA Is Not Your Destiny
A
7:05Anil BajnathGUEST
There's other applications, including pharmacogenomics and looking at whether or not you're gonna respond favorably or unfavorably to a drug or medication or intervention, and that's very clinically relevant.
A
7:18Anil BajnathGUEST
You know, um, statins, one of the most prescribed drugs and medications in the world, there's a certain genetic, uh, genotype, SLCO1B1, that's associated with being statin intolerant, and that risk for myopathy is increased.
A
7:34Anil BajnathGUEST
So very important, you know, for all those folks that are out there, and they're like, "Hey, I started a statin, and unfortunately, like my-- I-- fatigue and muscle and all..." Very important clinical molecular association that's not oftentimes looked at.
A
7:47Anil BajnathGUEST
And there are other, you know, nutrigenomic, uh, clinical applications in looking at how your genes responds to micronutrients and how micronutrients respond to your genes.
Uncovering the Science of Age-less Living: The Catalyst Method
E
12:06Ethan Hausman-MarquisHOST
Most clinicians have never opened one.
E
12:08Ethan Hausman-MarquisHOST
Concrete examples: SLCO1B1 encodes a transporter that moves statins into the liver.
E
12:16Ethan Hausman-MarquisHOST
Reduced function variants mean the drug lingers in circulation and in muscle instead, and muscle exposure is what produces statin myopathy.
E
12:25Ethan Hausman-MarquisHOST
There is a large population walking around convinced they are statin intolerant who are in fact intolerant of that statin at that dose and would do perfectly well on a different agent.
14 MINS LATER
E
26:11Ethan Hausman-MarquisHOST
Two previous statin attempts, both abandoned for muscle pain.
E
26:15Ethan Hausman-MarquisHOST
She had concluded she was statin intolerant, and her previous physicians had accepted that.
E
26:20Ethan Hausman-MarquisHOST
ApoB elevated, LPA elevated, pharmacogenomics, SLCO1B1 reduced function variant.
E
26:26Ethan Hausman-MarquisHOST
She was not statin intolerant.
Lirafugratinib + LITESPARK011
J
4:09John BazarHOST
It's a new drug, so we don't have a lot of real-world data, but there are precautions with either strong or moderate 3-4 inducers or inhibitors.
J
4:19John BazarHOST
It also inhibits P-glycoprotein, MATE1, MATE2K, OCT1, OCT2, OATP1B1, OATP1B3, breast cancer resistant protein, and BSEP, which is a transport protein I've never heard of.
J
4:30John BazarHOST
So it does inhibit a lot of other transporters and has a risk for other interactions.
J
4:36John BazarHOST
This inhibition of, like I say, OCT2 and MATE1 is probably why you see creatinine increased in 52%.